SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001422848-21-000160
Filing Date
2021-10-08
Accepted
2021-10-08 14:08:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 SEC SCHEDULE 13G SEC13G_Filing.htm SC 13G/A 16676
  Complete submission text file 0001422848-21-000160.txt   18170
Mailing Address 333 SOUTH HOPE STREET 55TH FLOOR LOS ANGELES CA 90071
Business Address 333 SOUTH HOPE STREET 55TH FLOOR LOS ANGELES CA 90071 213-486-9200
Capital Research Global Investors (Filed by) CIK: 0001422848 (see all company filings)

IRS No.: 951411037 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G/A

Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Subject) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87964 | Film No.: 211314914
SIC: 2834 Pharmaceutical Preparations